Information PortalData PortalKnowledge Portal

Data Matrix

Tools & Workflows

Documentation

3220.09 (Glytoucan)

Id:ab0b017e-e14f-5a57-8ccd-6c0fd771a5df

Glytoucan:G27550KO

Results found

Linked to

	Label	Description
	3220.09 has glycosequence GLYGEN.GLYCOSEQUENCE:G38376CI-GLYCOSEQ00050317 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	3220.09 synthesized by GLYCOSYLTRANSFERASE.REACTION:RXN00000023 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	3220.09 synthesized by GLYCOSYLTRANSFERASE.REACTION:RXN00000014 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	3220.09 has glycosequence GLYGEN.GLYCOSEQUENCE:G44027TT-GLYCOSEQ00133271 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	3220.09 synthesized by GLYCOSYLTRANSFERASE.REACTION:RXN00000002 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	3220.09 synthesized by GLYCOSYLTRANSFERASE.REACTION:RXN00000013 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	3220.09 has glycosequence GLYGEN.GLYCOSEQUENCE:G27550KO-GLYCOSEQ00183674 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	3220.09 synthesized by GLYCOSYLTRANSFERASE.REACTION:RXN00000076 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	3220.09 has canonical residue n-glycan b-d-galp 8 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	3220.09 synthesized by GLYCOSYLTRANSFERASE.REACTION:RXN00000073 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

3220.09 has glycosequence GLYGEN.GLYCOSEQUENCE:G38376CI-GLYCOSEQ00050317 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

3220.09 synthesized by GLYCOSYLTRANSFERASE.REACTION:RXN00000023 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

3220.09 synthesized by GLYCOSYLTRANSFERASE.REACTION:RXN00000014 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

3220.09 has glycosequence GLYGEN.GLYCOSEQUENCE:G44027TT-GLYCOSEQ00133271 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

3220.09 synthesized by GLYCOSYLTRANSFERASE.REACTION:RXN00000002 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

3220.09 synthesized by GLYCOSYLTRANSFERASE.REACTION:RXN00000013 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

3220.09 has glycosequence GLYGEN.GLYCOSEQUENCE:G27550KO-GLYCOSEQ00183674 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

3220.09 synthesized by GLYCOSYLTRANSFERASE.REACTION:RXN00000076 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

3220.09 has canonical residue n-glycan b-d-galp 8

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

3220.09 synthesized by GLYCOSYLTRANSFERASE.REACTION:RXN00000073 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

DISPLAY PER PAGE

Consortium

Community

Resources

@CFDE Workbench 2025

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

Consortium

Community

Resources

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2025

This repository is under review for potential modification in compliance with Administration directives.